(382) Efficacy, safety, and tolerability of Fulranumab as adjunctive therapy for cancer-related pain: a randomized, double-blind, placebo-controlled, multicenter studyN. Slatkin, N. Zaki,Panna Sanga,Steven Wang, J. Louie,Kathleen Kelly,John ThipphawongJOURNAL OF PAIN（2016）引用 3|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
